Global Animal Health Market

Animal Health Comprehensive Study by Type (Vaccines (Live Attenuated Vaccine, DNA Vaccines, Recombinant Vaccines and Inactivated Vaccines ), Feed Additives (Nutritional and Medicinal), Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics and others)), Application (Production Animals (Poultry, Swine, Cattle, Sheep & Goats and Fish), Companion Animals (Dogs, Cat, Horse and Others)), End-use (Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others) Players and Region - Global Market Outlook to 2028

Animal Health Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 4.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Animal health has become vital owing to importance of animals in ensuring global food safety. Growing people’s inclination towards animal protein requires animal’s well-being and prevention of diseases outbreaks. Fueled by growing popularity of pet ownership and rising demand for dairy products, the animal health industry continues its strong growth run.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia Pacific
UnitValue (USD Million)
Key Companies ProfiledBayer Animal Health [Germany], Ceva Animal Healthcare [United Kingdom], Elanco Animal Health [United States], Merck Ltd. [ India], Merial (Animal Health division of Sanofi) [France], Zoetis Animal Healthcare [United States], Pfizer [United States], Vétoquinol SA [France], Sanofi-Aventis [France], Bayer HealthCare [Germany], Virbac [France], Novartis [Switzerland], Boehringer Ingelheim [Germany] and Heska Corporation [United States]


According to AMA, the market for Animal Health is expected to register a CAGR of 4.8% during the forecast period to 2028. This growth is primarily driven by Rising Cases of Zoonotics, Increasing Pet Humanization and Favorable Government Initiatives.

Globally, a noticeable market trend is evident Rising Companion Animal Ownership The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Bayer Animal Health [Germany], Ceva Animal Healthcare [United Kingdom], Elanco Animal Health [United States], Merck Ltd. [ India], Merial (Animal Health division of Sanofi) [France], Zoetis Animal Healthcare [United States], Pfizer [United States], Vétoquinol SA [France], Sanofi-Aventis [France], Bayer HealthCare [Germany], Virbac [France], Novartis [Switzerland], Boehringer Ingelheim [Germany] and Heska Corporation [United States], etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. Animal Health market is a fragmented market due to the presence of various players. Companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

Key Developments in the Market:
In August 2020, Elanco Animal Health Incorporated acquired Bayer Animal Health for USD at 6.89 billion. This acquisition helped company to expand its presence in animal health market
Animal health and well-being is moving towards digitization. Biosensors, GPS systems and computer vision technologies are being adopted. An Israeli company, Cattle Watch offering a full array of integrated GPS paraphernalia for livestock. The system not only monitors health conditions and predator activity, it can also create invisible fences. Though, this technology is in infancy stage but digital disruption in animal health is on the card.

Regulatory Insights:
FDA regulates the drugs, devices and feed given to or used on over one hundred million companion and food-producing animals in the United States. Several other government and non-government organizations also play a role in animal health. As per FDA, "the drug is safe and effective for a specific use in a specific animal species. If the drug is for use in food-producing animals, the drug company must also prove that food products made from treated animals are safe for people to eat.

Influencing Trend:
Rising Companion Animal Ownership and Growing Awareness About Healthy Food and Animal Protein

Market Growth Drivers:
Rising Cases of Zoonotics, Increasing Pet Humanization and Favorable Government Initiatives

Challenges:
Stringent Regulations on Antibiotics and Lack of Resources in Emerging Nation for New Product Development

Restraints:
Low Expenditure on Animal Health In Emerging Countries and High Cost Involved in New Drug Development

Opportunities:
Technically Advanced Animal Drugs Development and Rising Disposable Income in Emerging Countries

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Animal Health Market
- Analysis about New Entrants in Animal Health Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Animal Health Study Sheds Light on
— The Animal Health Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Animal Health industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Animal Health industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Vaccines (Live Attenuated Vaccine, DNA Vaccines, Recombinant Vaccines and Inactivated Vaccines )
  • Feed Additives (Nutritional and Medicinal)
  • Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics and others)
By Application
  • Production Animals (Poultry, Swine, Cattle, Sheep & Goats and Fish)
  • Companion Animals (Dogs, Cat, Horse and Others)
By End-use
  • Reference Laboratories
  • Point-of-care Testing/In-house Testing
  • Veterinary Hospitals & Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Cases of Zoonotics
      • 3.2.2. Increasing Pet Humanization
      • 3.2.3. Favorable Government Initiatives
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations on Antibiotics
      • 3.3.2. Lack of Resources in Emerging Nation for New Product Development
    • 3.4. Market Trends
      • 3.4.1. Rising Companion Animal Ownership
      • 3.4.2. Growing Awareness About Healthy Food and Animal Protein
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Health, by Type, Application, End-use and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Animal Health (Value)
      • 5.2.1. Global Animal Health by: Type (Value)
        • 5.2.1.1. Vaccines (Live Attenuated Vaccine, DNA Vaccines, Recombinant Vaccines and Inactivated Vaccines )
        • 5.2.1.2. Feed Additives (Nutritional and Medicinal)
        • 5.2.1.3. Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics and others)
      • 5.2.2. Global Animal Health by: Application (Value)
        • 5.2.2.1. Production Animals (Poultry, Swine, Cattle, Sheep & Goats and Fish)
        • 5.2.2.2. Companion Animals (Dogs, Cat, Horse and Others)
      • 5.2.3. Global Animal Health by: End-use (Value)
        • 5.2.3.1. Reference Laboratories
        • 5.2.3.2. Point-of-care Testing/In-house Testing
        • 5.2.3.3. Veterinary Hospitals & Clinics
        • 5.2.3.4. Others
      • 5.2.4. Global Animal Health Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Animal Health (Price)
      • 5.3.1. Global Animal Health by: Type (Price)
  • 6. Animal Health: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer Animal Health [Germany]
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ceva Animal Healthcare [United Kingdom]
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elanco Animal Health [United States]
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck Ltd. [ India]
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merial (Animal Health division of Sanofi) [France]
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Zoetis Animal Healthcare [United States]
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer [United States]
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vétoquinol SA [France]
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sanofi-Aventis [France]
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Bayer HealthCare [Germany]
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Virbac [France]
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Novartis [Switzerland]
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Boehringer Ingelheim [Germany]
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Heska Corporation [United States]
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Animal Health Sale, by Type, Application, End-use and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Animal Health (Value)
      • 7.2.1. Global Animal Health by: Type (Value)
        • 7.2.1.1. Vaccines (Live Attenuated Vaccine, DNA Vaccines, Recombinant Vaccines and Inactivated Vaccines )
        • 7.2.1.2. Feed Additives (Nutritional and Medicinal)
        • 7.2.1.3. Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics and others)
      • 7.2.2. Global Animal Health by: Application (Value)
        • 7.2.2.1. Production Animals (Poultry, Swine, Cattle, Sheep & Goats and Fish)
        • 7.2.2.2. Companion Animals (Dogs, Cat, Horse and Others)
      • 7.2.3. Global Animal Health by: End-use (Value)
        • 7.2.3.1. Reference Laboratories
        • 7.2.3.2. Point-of-care Testing/In-house Testing
        • 7.2.3.3. Veterinary Hospitals & Clinics
        • 7.2.3.4. Others
      • 7.2.4. Global Animal Health Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Animal Health (Price)
      • 7.3.1. Global Animal Health by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Health: by Type(USD Million)
  • Table 2. Animal Health Vaccines (Live Attenuated Vaccine, DNA Vaccines, Recombinant Vaccines and Inactivated Vaccines ) , by Region USD Million (2017-2022)
  • Table 3. Animal Health Feed Additives (Nutritional and Medicinal) , by Region USD Million (2017-2022)
  • Table 4. Animal Health Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics and others) , by Region USD Million (2017-2022)
  • Table 5. Animal Health: by Application(USD Million)
  • Table 6. Animal Health Production Animals (Poultry, Swine, Cattle, Sheep & Goats and Fish) , by Region USD Million (2017-2022)
  • Table 7. Animal Health Companion Animals (Dogs, Cat, Horse and Others) , by Region USD Million (2017-2022)
  • Table 8. Animal Health: by End-use(USD Million)
  • Table 9. Animal Health Reference Laboratories , by Region USD Million (2017-2022)
  • Table 10. Animal Health Point-of-care Testing/In-house Testing , by Region USD Million (2017-2022)
  • Table 11. Animal Health Veterinary Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 12. Animal Health Others , by Region USD Million (2017-2022)
  • Table 13. South America Animal Health, by Country USD Million (2017-2022)
  • Table 14. South America Animal Health, by Type USD Million (2017-2022)
  • Table 15. South America Animal Health, by Application USD Million (2017-2022)
  • Table 16. South America Animal Health, by End-use USD Million (2017-2022)
  • Table 17. Brazil Animal Health, by Type USD Million (2017-2022)
  • Table 18. Brazil Animal Health, by Application USD Million (2017-2022)
  • Table 19. Brazil Animal Health, by End-use USD Million (2017-2022)
  • Table 20. Argentina Animal Health, by Type USD Million (2017-2022)
  • Table 21. Argentina Animal Health, by Application USD Million (2017-2022)
  • Table 22. Argentina Animal Health, by End-use USD Million (2017-2022)
  • Table 23. Rest of South America Animal Health, by Type USD Million (2017-2022)
  • Table 24. Rest of South America Animal Health, by Application USD Million (2017-2022)
  • Table 25. Rest of South America Animal Health, by End-use USD Million (2017-2022)
  • Table 26. Asia Pacific Animal Health, by Country USD Million (2017-2022)
  • Table 27. Asia Pacific Animal Health, by Type USD Million (2017-2022)
  • Table 28. Asia Pacific Animal Health, by Application USD Million (2017-2022)
  • Table 29. Asia Pacific Animal Health, by End-use USD Million (2017-2022)
  • Table 30. China Animal Health, by Type USD Million (2017-2022)
  • Table 31. China Animal Health, by Application USD Million (2017-2022)
  • Table 32. China Animal Health, by End-use USD Million (2017-2022)
  • Table 33. Japan Animal Health, by Type USD Million (2017-2022)
  • Table 34. Japan Animal Health, by Application USD Million (2017-2022)
  • Table 35. Japan Animal Health, by End-use USD Million (2017-2022)
  • Table 36. India Animal Health, by Type USD Million (2017-2022)
  • Table 37. India Animal Health, by Application USD Million (2017-2022)
  • Table 38. India Animal Health, by End-use USD Million (2017-2022)
  • Table 39. South Korea Animal Health, by Type USD Million (2017-2022)
  • Table 40. South Korea Animal Health, by Application USD Million (2017-2022)
  • Table 41. South Korea Animal Health, by End-use USD Million (2017-2022)
  • Table 42. Taiwan Animal Health, by Type USD Million (2017-2022)
  • Table 43. Taiwan Animal Health, by Application USD Million (2017-2022)
  • Table 44. Taiwan Animal Health, by End-use USD Million (2017-2022)
  • Table 45. Australia Animal Health, by Type USD Million (2017-2022)
  • Table 46. Australia Animal Health, by Application USD Million (2017-2022)
  • Table 47. Australia Animal Health, by End-use USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Animal Health, by Type USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Animal Health, by Application USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Animal Health, by End-use USD Million (2017-2022)
  • Table 51. Europe Animal Health, by Country USD Million (2017-2022)
  • Table 52. Europe Animal Health, by Type USD Million (2017-2022)
  • Table 53. Europe Animal Health, by Application USD Million (2017-2022)
  • Table 54. Europe Animal Health, by End-use USD Million (2017-2022)
  • Table 55. Germany Animal Health, by Type USD Million (2017-2022)
  • Table 56. Germany Animal Health, by Application USD Million (2017-2022)
  • Table 57. Germany Animal Health, by End-use USD Million (2017-2022)
  • Table 58. France Animal Health, by Type USD Million (2017-2022)
  • Table 59. France Animal Health, by Application USD Million (2017-2022)
  • Table 60. France Animal Health, by End-use USD Million (2017-2022)
  • Table 61. Italy Animal Health, by Type USD Million (2017-2022)
  • Table 62. Italy Animal Health, by Application USD Million (2017-2022)
  • Table 63. Italy Animal Health, by End-use USD Million (2017-2022)
  • Table 64. United Kingdom Animal Health, by Type USD Million (2017-2022)
  • Table 65. United Kingdom Animal Health, by Application USD Million (2017-2022)
  • Table 66. United Kingdom Animal Health, by End-use USD Million (2017-2022)
  • Table 67. Netherlands Animal Health, by Type USD Million (2017-2022)
  • Table 68. Netherlands Animal Health, by Application USD Million (2017-2022)
  • Table 69. Netherlands Animal Health, by End-use USD Million (2017-2022)
  • Table 70. Rest of Europe Animal Health, by Type USD Million (2017-2022)
  • Table 71. Rest of Europe Animal Health, by Application USD Million (2017-2022)
  • Table 72. Rest of Europe Animal Health, by End-use USD Million (2017-2022)
  • Table 73. MEA Animal Health, by Country USD Million (2017-2022)
  • Table 74. MEA Animal Health, by Type USD Million (2017-2022)
  • Table 75. MEA Animal Health, by Application USD Million (2017-2022)
  • Table 76. MEA Animal Health, by End-use USD Million (2017-2022)
  • Table 77. Middle East Animal Health, by Type USD Million (2017-2022)
  • Table 78. Middle East Animal Health, by Application USD Million (2017-2022)
  • Table 79. Middle East Animal Health, by End-use USD Million (2017-2022)
  • Table 80. Africa Animal Health, by Type USD Million (2017-2022)
  • Table 81. Africa Animal Health, by Application USD Million (2017-2022)
  • Table 82. Africa Animal Health, by End-use USD Million (2017-2022)
  • Table 83. North America Animal Health, by Country USD Million (2017-2022)
  • Table 84. North America Animal Health, by Type USD Million (2017-2022)
  • Table 85. North America Animal Health, by Application USD Million (2017-2022)
  • Table 86. North America Animal Health, by End-use USD Million (2017-2022)
  • Table 87. United States Animal Health, by Type USD Million (2017-2022)
  • Table 88. United States Animal Health, by Application USD Million (2017-2022)
  • Table 89. United States Animal Health, by End-use USD Million (2017-2022)
  • Table 90. Canada Animal Health, by Type USD Million (2017-2022)
  • Table 91. Canada Animal Health, by Application USD Million (2017-2022)
  • Table 92. Canada Animal Health, by End-use USD Million (2017-2022)
  • Table 93. Mexico Animal Health, by Type USD Million (2017-2022)
  • Table 94. Mexico Animal Health, by Application USD Million (2017-2022)
  • Table 95. Mexico Animal Health, by End-use USD Million (2017-2022)
  • Table 96. Animal Health: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Animal Health: by Type(USD Million)
  • Table 112. Animal Health Vaccines (Live Attenuated Vaccine, DNA Vaccines, Recombinant Vaccines and Inactivated Vaccines ) , by Region USD Million (2023-2028)
  • Table 113. Animal Health Feed Additives (Nutritional and Medicinal) , by Region USD Million (2023-2028)
  • Table 114. Animal Health Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics and others) , by Region USD Million (2023-2028)
  • Table 115. Animal Health: by Application(USD Million)
  • Table 116. Animal Health Production Animals (Poultry, Swine, Cattle, Sheep & Goats and Fish) , by Region USD Million (2023-2028)
  • Table 117. Animal Health Companion Animals (Dogs, Cat, Horse and Others) , by Region USD Million (2023-2028)
  • Table 118. Animal Health: by End-use(USD Million)
  • Table 119. Animal Health Reference Laboratories , by Region USD Million (2023-2028)
  • Table 120. Animal Health Point-of-care Testing/In-house Testing , by Region USD Million (2023-2028)
  • Table 121. Animal Health Veterinary Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 122. Animal Health Others , by Region USD Million (2023-2028)
  • Table 123. South America Animal Health, by Country USD Million (2023-2028)
  • Table 124. South America Animal Health, by Type USD Million (2023-2028)
  • Table 125. South America Animal Health, by Application USD Million (2023-2028)
  • Table 126. South America Animal Health, by End-use USD Million (2023-2028)
  • Table 127. Brazil Animal Health, by Type USD Million (2023-2028)
  • Table 128. Brazil Animal Health, by Application USD Million (2023-2028)
  • Table 129. Brazil Animal Health, by End-use USD Million (2023-2028)
  • Table 130. Argentina Animal Health, by Type USD Million (2023-2028)
  • Table 131. Argentina Animal Health, by Application USD Million (2023-2028)
  • Table 132. Argentina Animal Health, by End-use USD Million (2023-2028)
  • Table 133. Rest of South America Animal Health, by Type USD Million (2023-2028)
  • Table 134. Rest of South America Animal Health, by Application USD Million (2023-2028)
  • Table 135. Rest of South America Animal Health, by End-use USD Million (2023-2028)
  • Table 136. Asia Pacific Animal Health, by Country USD Million (2023-2028)
  • Table 137. Asia Pacific Animal Health, by Type USD Million (2023-2028)
  • Table 138. Asia Pacific Animal Health, by Application USD Million (2023-2028)
  • Table 139. Asia Pacific Animal Health, by End-use USD Million (2023-2028)
  • Table 140. China Animal Health, by Type USD Million (2023-2028)
  • Table 141. China Animal Health, by Application USD Million (2023-2028)
  • Table 142. China Animal Health, by End-use USD Million (2023-2028)
  • Table 143. Japan Animal Health, by Type USD Million (2023-2028)
  • Table 144. Japan Animal Health, by Application USD Million (2023-2028)
  • Table 145. Japan Animal Health, by End-use USD Million (2023-2028)
  • Table 146. India Animal Health, by Type USD Million (2023-2028)
  • Table 147. India Animal Health, by Application USD Million (2023-2028)
  • Table 148. India Animal Health, by End-use USD Million (2023-2028)
  • Table 149. South Korea Animal Health, by Type USD Million (2023-2028)
  • Table 150. South Korea Animal Health, by Application USD Million (2023-2028)
  • Table 151. South Korea Animal Health, by End-use USD Million (2023-2028)
  • Table 152. Taiwan Animal Health, by Type USD Million (2023-2028)
  • Table 153. Taiwan Animal Health, by Application USD Million (2023-2028)
  • Table 154. Taiwan Animal Health, by End-use USD Million (2023-2028)
  • Table 155. Australia Animal Health, by Type USD Million (2023-2028)
  • Table 156. Australia Animal Health, by Application USD Million (2023-2028)
  • Table 157. Australia Animal Health, by End-use USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific Animal Health, by Type USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Animal Health, by Application USD Million (2023-2028)
  • Table 160. Rest of Asia-Pacific Animal Health, by End-use USD Million (2023-2028)
  • Table 161. Europe Animal Health, by Country USD Million (2023-2028)
  • Table 162. Europe Animal Health, by Type USD Million (2023-2028)
  • Table 163. Europe Animal Health, by Application USD Million (2023-2028)
  • Table 164. Europe Animal Health, by End-use USD Million (2023-2028)
  • Table 165. Germany Animal Health, by Type USD Million (2023-2028)
  • Table 166. Germany Animal Health, by Application USD Million (2023-2028)
  • Table 167. Germany Animal Health, by End-use USD Million (2023-2028)
  • Table 168. France Animal Health, by Type USD Million (2023-2028)
  • Table 169. France Animal Health, by Application USD Million (2023-2028)
  • Table 170. France Animal Health, by End-use USD Million (2023-2028)
  • Table 171. Italy Animal Health, by Type USD Million (2023-2028)
  • Table 172. Italy Animal Health, by Application USD Million (2023-2028)
  • Table 173. Italy Animal Health, by End-use USD Million (2023-2028)
  • Table 174. United Kingdom Animal Health, by Type USD Million (2023-2028)
  • Table 175. United Kingdom Animal Health, by Application USD Million (2023-2028)
  • Table 176. United Kingdom Animal Health, by End-use USD Million (2023-2028)
  • Table 177. Netherlands Animal Health, by Type USD Million (2023-2028)
  • Table 178. Netherlands Animal Health, by Application USD Million (2023-2028)
  • Table 179. Netherlands Animal Health, by End-use USD Million (2023-2028)
  • Table 180. Rest of Europe Animal Health, by Type USD Million (2023-2028)
  • Table 181. Rest of Europe Animal Health, by Application USD Million (2023-2028)
  • Table 182. Rest of Europe Animal Health, by End-use USD Million (2023-2028)
  • Table 183. MEA Animal Health, by Country USD Million (2023-2028)
  • Table 184. MEA Animal Health, by Type USD Million (2023-2028)
  • Table 185. MEA Animal Health, by Application USD Million (2023-2028)
  • Table 186. MEA Animal Health, by End-use USD Million (2023-2028)
  • Table 187. Middle East Animal Health, by Type USD Million (2023-2028)
  • Table 188. Middle East Animal Health, by Application USD Million (2023-2028)
  • Table 189. Middle East Animal Health, by End-use USD Million (2023-2028)
  • Table 190. Africa Animal Health, by Type USD Million (2023-2028)
  • Table 191. Africa Animal Health, by Application USD Million (2023-2028)
  • Table 192. Africa Animal Health, by End-use USD Million (2023-2028)
  • Table 193. North America Animal Health, by Country USD Million (2023-2028)
  • Table 194. North America Animal Health, by Type USD Million (2023-2028)
  • Table 195. North America Animal Health, by Application USD Million (2023-2028)
  • Table 196. North America Animal Health, by End-use USD Million (2023-2028)
  • Table 197. United States Animal Health, by Type USD Million (2023-2028)
  • Table 198. United States Animal Health, by Application USD Million (2023-2028)
  • Table 199. United States Animal Health, by End-use USD Million (2023-2028)
  • Table 200. Canada Animal Health, by Type USD Million (2023-2028)
  • Table 201. Canada Animal Health, by Application USD Million (2023-2028)
  • Table 202. Canada Animal Health, by End-use USD Million (2023-2028)
  • Table 203. Mexico Animal Health, by Type USD Million (2023-2028)
  • Table 204. Mexico Animal Health, by Application USD Million (2023-2028)
  • Table 205. Mexico Animal Health, by End-use USD Million (2023-2028)
  • Table 206. Animal Health: by Type(USD/Units)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Health: by Type USD Million (2017-2022)
  • Figure 5. Global Animal Health: by Application USD Million (2017-2022)
  • Figure 6. Global Animal Health: by End-use USD Million (2017-2022)
  • Figure 7. South America Animal Health Share (%), by Country
  • Figure 8. Asia Pacific Animal Health Share (%), by Country
  • Figure 9. Europe Animal Health Share (%), by Country
  • Figure 10. MEA Animal Health Share (%), by Country
  • Figure 11. North America Animal Health Share (%), by Country
  • Figure 12. Global Animal Health: by Type USD/Units (2017-2022)
  • Figure 13. Global Animal Health share by Players 2022 (%)
  • Figure 14. Global Animal Health share by Players (Top 3) 2022(%)
  • Figure 15. Global Animal Health share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bayer Animal Health [Germany] Revenue, Net Income and Gross profit
  • Figure 18. Bayer Animal Health [Germany] Revenue: by Geography 2022
  • Figure 19. Ceva Animal Healthcare [United Kingdom] Revenue, Net Income and Gross profit
  • Figure 20. Ceva Animal Healthcare [United Kingdom] Revenue: by Geography 2022
  • Figure 21. Elanco Animal Health [United States] Revenue, Net Income and Gross profit
  • Figure 22. Elanco Animal Health [United States] Revenue: by Geography 2022
  • Figure 23. Merck Ltd. [ India] Revenue, Net Income and Gross profit
  • Figure 24. Merck Ltd. [ India] Revenue: by Geography 2022
  • Figure 25. Merial (Animal Health division of Sanofi) [France] Revenue, Net Income and Gross profit
  • Figure 26. Merial (Animal Health division of Sanofi) [France] Revenue: by Geography 2022
  • Figure 27. Zoetis Animal Healthcare [United States] Revenue, Net Income and Gross profit
  • Figure 28. Zoetis Animal Healthcare [United States] Revenue: by Geography 2022
  • Figure 29. Pfizer [United States] Revenue, Net Income and Gross profit
  • Figure 30. Pfizer [United States] Revenue: by Geography 2022
  • Figure 31. Vétoquinol SA [France] Revenue, Net Income and Gross profit
  • Figure 32. Vétoquinol SA [France] Revenue: by Geography 2022
  • Figure 33. Sanofi-Aventis [France] Revenue, Net Income and Gross profit
  • Figure 34. Sanofi-Aventis [France] Revenue: by Geography 2022
  • Figure 35. Bayer HealthCare [Germany] Revenue, Net Income and Gross profit
  • Figure 36. Bayer HealthCare [Germany] Revenue: by Geography 2022
  • Figure 37. Virbac [France] Revenue, Net Income and Gross profit
  • Figure 38. Virbac [France] Revenue: by Geography 2022
  • Figure 39. Novartis [Switzerland] Revenue, Net Income and Gross profit
  • Figure 40. Novartis [Switzerland] Revenue: by Geography 2022
  • Figure 41. Boehringer Ingelheim [Germany] Revenue, Net Income and Gross profit
  • Figure 42. Boehringer Ingelheim [Germany] Revenue: by Geography 2022
  • Figure 43. Heska Corporation [United States] Revenue, Net Income and Gross profit
  • Figure 44. Heska Corporation [United States] Revenue: by Geography 2022
  • Figure 45. Global Animal Health: by Type USD Million (2023-2028)
  • Figure 46. Global Animal Health: by Application USD Million (2023-2028)
  • Figure 47. Global Animal Health: by End-use USD Million (2023-2028)
  • Figure 48. South America Animal Health Share (%), by Country
  • Figure 49. Asia Pacific Animal Health Share (%), by Country
  • Figure 50. Europe Animal Health Share (%), by Country
  • Figure 51. MEA Animal Health Share (%), by Country
  • Figure 52. North America Animal Health Share (%), by Country
  • Figure 53. Global Animal Health: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Bayer Animal Health [Germany]
  • Ceva Animal Healthcare [United Kingdom]
  • Elanco Animal Health [United States]
  • Merck Ltd. [ India]
  • Merial (Animal Health division of Sanofi) [France]
  • Zoetis Animal Healthcare [United States]
  • Pfizer [United States]
  • Vétoquinol SA [France]
  • Sanofi-Aventis [France]
  • Bayer HealthCare [Germany]
  • Virbac [France]
  • Novartis [Switzerland]
  • Boehringer Ingelheim [Germany]
  • Heska Corporation [United States]
Additional players considered in the study are as follows:
Zoetis [United States] , iMEDGlobal [United States] , PAREXEL [United States] , Bristol-Myers Squibb [United States] , GlaxoSmithKline plc [United Kingdom] , inVentiv Health, Inc [United States] , Nutreco [Netherlands]
Select User Access Type

Key Highlights of Report


Jun 2023 201 Pages 66 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Animal Health Market Quantitative research analysis
Global Animal Health Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Animal Health market are Bayer Animal Health [Germany], Ceva Animal Healthcare [United Kingdom], Elanco Animal Health [United States], Merck Ltd. [ India], Merial (Animal Health division of Sanofi) [France], Zoetis Animal Healthcare [United States], Pfizer [United States], Vétoquinol SA [France], Sanofi-Aventis [France], Bayer HealthCare [Germany], Virbac [France], Novartis [Switzerland], Boehringer Ingelheim [Germany] and Heska Corporation [United States], to name a few.
North America is dominating the Animal Health Market.
"Stringent Regulations on Antibiotics " is seen as one of the major challenges by many Industry Players of Animal Health Market
The Animal Health market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Animal Health market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Animal Health Market Report?

Have a Query? Click Here

Other Related Reports

Antibody Drugs Comprehensive Study by Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Polyclonal Antibodies), Application (Central Nervous System (CNS) Disorders, Cancers, Autoimmune Disorders...
$ 3350
Capsule Shell Comprehensive Study by Type (Gelatin Capsule (Hard Gelatin Capsule, Soft Gelatin Capsule), Non-Gelatin Capsule), Application (Antibiotic Drugs, Vitamin and Dietary Supplements, Antacid ...
$ 3750
Diarrhea Drug Comprehensive Study by Type (Adult, Children), Application (Family, Hospital), Form (Syringe, Tablets), Dosage (10 mg, 15 mg, 20 mg, 30 mg) Players and Region - Global Market Outlook to...
$ 3500
Caspase 3 Comprehensive Study by Type (1G3-Cu, BaxM-159, Emricasan, IDN-7314, Others), Application (Liver Cirrhosis, Liver Failure, Pulmonary Fibrosis, Solid Tumor, Others) Players and Region - Globa...
$ 3400
Docetaxel Comprehensive Study by Type (40 mg/ml, 20 mg/ml, 10 mg/ml), Application (Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Gastric Adenocarcinoma Cancer, Head and Neck Cancer), En...
$ 3650
Doxorubicin Comprehensive Study by Type (Lyophilized Powder, Doxorubicin Injection), Application (Ovarian, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Breast Cancer, Gastric Cancer, Oth...
$ 3450